Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
ABIOMED Stock Forecast NASDAQ:ABMD
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-04-06 | 38.28% | Wolfe Research | $330.00 | Initiates Coverage On | Peer Perform |
| 2022-02-04 | 36.18% | SVB Leerink | $345.00 $325.00 | Maintains | Market Perform |
| 2022-02-04 | 15.23% | Morgan Stanley | $292.00 $275.00 | Maintains | Underweight |
| 2022-01-07 | 22.35% | Morgan Stanley | $269.00 $292.00 | Maintains | Underweight |
| 2021-08-06 | 57.13% | SVB Leerink | $335.00 $375.00 | Maintains | Market Perform |
| 2021-07-20 | 40.37% | SVB Leerink | $355.00 $335.00 | Maintains | Market Perform |
| 2021-06-18 | 50.85% | Deutsche Bank | $360.00 | Initiates Coverage On | Buy |
| 2021-01-29 | 2.66% | Morgan Stanley | $238.00 $245.00 | Maintains | Underweight |
| 2021-01-29 | 57.13% | SVB Leerink | $320.00 $375.00 | Maintains | Market Perform |
| 2020-12-15 | -0.27% | Morgan Stanley | $217.00 $238.00 | Maintains | Underweight |
| 2020-10-12 | 17.33% | SVB Leerink | $335.00 $280.00 | Maintains | Market Perform |
| 2020-08-07 | 40.37% | SVB Leerink | $280.00 $335.00 | Maintains | Market Perform |
| 2020-08-07 | -9.07% | Morgan Stanley | $152.00 $217.00 | Maintains | Underweight |
| 2020-05-28 | -5.72% | SVB Leerink | $195.00 $225.00 | Reiterates | Market Perform |
| 2020-05-01 | -36.31% | Morgan Stanley | $149.00 $152.00 | Maintains | Underweight |
| 2020-05-01 | -18.29% | SVB Leerink | $175.00 $195.00 | Maintains | Market Perform |
| 2020-04-27 | -26.67% | SVB Leerink | $220.00 $175.00 | Downgrades | Outperform Market Perform |
| 2020-03-27 | -37.57% | Morgan Stanley | $165.00 $149.00 | Maintains | Underweight |
| 2020-03-23 | -35.05% | Stephens & Co. | $240.00 $155.00 | Maintains | Overweight |
| 2020-02-12 | -30.86% | Morgan Stanley | $198.00 $165.00 | Downgrades | Equal-Weight Underweight |
| 2019-12-17 | -17.03% | Morgan Stanley | $215.00 $198.00 | Maintains | Equal-Weight |
| 2019-10-29 | - | Raymond James | - | Downgrades | Outperform Market Perform |
| 2019-08-02 | - | BTIG | - | Downgrades | Buy Neutral |
| 2019-08-02 | - | Guggenheim | - | Downgrades | Buy Neutral |
| 2019-08-02 | -9.91% | Morgan Stanley | $325.00 $215.00 | Downgrades | Overweight Equal-Weight |
ABMD Stock Trend
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $227.97 is broken, it will firstly indicate a stronger fall rate.
Given the current short-term trend, the stock is expected to fall -15.41% during the next 3 months and, with a 90% probability hold a price between $192.84 and $260.63 at the end of this 3-month period.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-23 | $227.05 | $267.12 | $307.19 |
| 2022-05-24 | $226.13 | $266.20 | $306.27 |
| 2022-05-25 | $225.21 | $265.28 | $305.35 |
| 2022-05-26 | $224.29 | $264.36 | $304.43 |
| 2022-05-27 | $223.37 | $263.44 | $303.51 |
| 2022-05-31 | $222.45 | $262.52 | $302.59 |
| 2022-06-01 | $221.53 | $261.60 | $301.67 |
| 2022-06-02 | $220.61 | $260.68 | $300.75 |
| 2022-06-03 | $219.69 | $259.76 | $299.83 |
| 2022-06-06 | $218.77 | $258.84 | $298.91 |
| 2022-06-07 | $217.85 | $257.92 | $297.99 |
| 2022-06-08 | $216.93 | $257.00 | $297.07 |
| 2022-06-09 | $216.01 | $256.08 | $296.15 |
| 2022-06-10 | $215.09 | $255.16 | $295.23 |
| 2022-06-13 | $214.17 | $254.24 | $294.31 |
| 2022-06-14 | $213.25 | $253.32 | $293.39 |
| 2022-06-15 | $212.33 | $252.40 | $292.47 |
| 2022-06-16 | $211.41 | $251.48 | $291.55 |
| 2022-06-17 | $210.49 | $250.56 | $290.63 |
| 2022-06-21 | $209.57 | $249.64 | $289.71 |
| 2022-06-22 | $208.66 | $248.72 | $288.79 |
| 2022-06-23 | $207.74 | $247.80 | $287.87 |
| 2022-06-24 | $206.82 | $246.88 | $286.95 |
| 2022-06-27 | $205.90 | $245.96 | $286.03 |
| 2022-06-28 | $204.98 | $245.04 | $285.11 |
| 2022-06-29 | $204.06 | $244.12 | $284.19 |
| 2022-06-30 | $203.14 | $243.20 | $283.27 |
| 2022-07-01 | $202.22 | $242.28 | $282.35 |
| 2022-07-05 | $201.30 | $241.36 | $281.43 |
| 2022-07-06 | $200.38 | $240.44 | $280.51 |
ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP that provides partial circulatory support using an extracorporeal bypass control unit; I... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
